PubMed:32235387 / 730-883
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 117-124 | NCBITaxon:33208 | denotes | animals |
LitCovid-sentences-v1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T7 | 0-153 | Sentence | denotes | While most of the vaccines are under design and preparation, there are some that have entered efficacy evaluation in animals and initial clinical trials. |
LitCovid-TimeML
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
tok129 | 0-5 | IN | denotes | While |
tok130 | 6-10 | JJS | denotes | most |
tok131 | 11-13 | IN | denotes | of |
tok132 | 14-17 | DT | denotes | the |
tok133 | 18-26 | NNS | denotes | vaccines |
tok134 | 27-30 | VBP | denotes | are |
tok135 | 31-36 | IN | denotes | under |
tok136 | 37-43 | NN | denotes | design |
tok137 | 44-47 | CC | denotes | and |
tok138 | 48-59 | NN | denotes | preparation |
tok139 | 59-60 | , | denotes | , |
tok140 | 61-66 | EX | denotes | there |
tok141 | 67-70 | VBP | denotes | are |
tok142 | 71-75 | DT | denotes | some |
tok143 | 76-80 | WDT | denotes | that |
tok144 | 81-85 | VBP | denotes | have |
tok145 | 86-93 | VBN | denotes | entered |
tok146 | 94-102 | NN | denotes | efficacy |
tok147 | 103-113 | NN | denotes | evaluation |
tok148 | 114-116 | IN | denotes | in |
tok149 | 117-124 | NNS | denotes | animals |
tok150 | 125-128 | CC | denotes | and |
tok151 | 129-136 | JJ | denotes | initial |
tok152 | 137-145 | JJ | denotes | clinical |
tok153 | 146-152 | NNS | denotes | trials |
tok154 | 152-153 | . | denotes | . |
lookup16 | 114-116 | country_code | denotes | in |
event6 | 86-93 | ASPECTUAL | denotes | entered |